Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration

J Cancer Res Clin Oncol. 2005 Nov;131(11):723-32. doi: 10.1007/s00432-005-0014-3. Epub 2005 Nov 1.

Abstract

Purpose: Investigation of cell migration and proliferation of human glioma cell line spheroids (CLS) and evaluation of morphology, apoptosis, and immunohistochemical expression of MIB-1, p53, and p21 of organotypic muticellular spheroids (OMS) following cisplatin (CDDP) and irradiation (RT).

Material and methods: Spheroids of the GaMg glioma cell line and OMS prepared from biopsy tissue of six glioblastoma patients were used. Radiochemosensitvity (5 microg/ml CDDP followed by RT) was determined using migration and proliferation assays on CLS. In OMS, histology and immunohistochemical studies of MIB-1, p53, and p21 expression were examined 24 and 48 h following treatment.

Results: Combination treatment led to a migration inhibition of 38% (CDDP 13%; RT 27%) and specific growth delay of 2.6 (CDDP 1.3; RT 2.1) in CLS. Cell cycle analysis after combination treatment showed an accumulation of cells in the G2/M phase. In OMS, apoptosis increased, cell proliferation decreased, and p53/p21 expression increased more pronounced following CDDP+RT. No morphological damage was observed.

Conclusion: CDDP can lead to enhancement of the RT effect in spheroids of both human glioma cell line spheroids and biopsy spheroids from glioblastoma specimens. The exerted effect is additive rather than synergistic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis / radiation effects
  • Biomarkers, Tumor / metabolism*
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Movement / radiation effects
  • Cell Proliferation / drug effects
  • Cell Proliferation / radiation effects
  • Chemotherapy, Adjuvant
  • Cisplatin / pharmacology*
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Flow Cytometry
  • Gene Expression Regulation, Neoplastic
  • Glioma / drug therapy*
  • Glioma / metabolism
  • Glioma / pathology
  • Glioma / radiotherapy*
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / metabolism
  • Radiotherapy, Adjuvant
  • Spheroids, Cellular
  • Time Factors
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Ki-67 Antigen
  • Tumor Suppressor Protein p53
  • Cisplatin